Stefan Colin John Taylor

Title: The Innovations of Stefan Colin John Taylor

Introduction

Stefan Colin John Taylor is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

One of his latest patents involves anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide. This invention comprises several key components: (1) anhydrous crystalline forms of the compound, (2) pharmaceutical compositions that include at least one such form, (3) methods for treating a phosphodiesterase-5-mediated condition using at least one such form, and (4) methods for preparing these forms. The compound has a specific structure that is crucial for its functionality.

Career Highlights

Throughout his career, Stefan has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Rigel Pharmaceuticals, Incorporated. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Stefan has collaborated with several notable individuals in his field, including Patricia Ann Basford and Peter Thomas Stephenson. These collaborations have likely contributed to the advancement of his research and inventions.

Conclusion

Stefan Colin John Taylor is a distinguished inventor whose work in pharmaceuticals has led to multiple patents and innovative solutions for medical treatments. His contributions continue to shape the landscape of pharmaceutical research and development.